Michelle L. Basil - May 15, 2024 Form 4 Insider Report for HAEMONETICS CORP (HAE)

Signature
/s/ Thomas V. Powers, attorney-in-fact for Ms. Basil
Stock symbol
HAE
Transactions as of
May 15, 2024
Transactions value $
-$177,119
Form type
4
Date filed
5/17/2024, 05:02 PM
Previous filing
Oct 24, 2023
Next filing
May 21, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HAE Common Stock Tax liability -$40.1K -416 -1.29% $96.49 31.9K May 15, 2024 Direct F1, F2
transaction HAE Common Stock Tax liability -$42.3K -446 -1.4% $94.80 31.4K May 16, 2024 Direct F1, F2
transaction HAE Common Stock Sale -$94.7K -985 -3.14% $96.14 30.4K May 16, 2024 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Represents shares withheld for tax obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I.
F2 This number includes unvested RSUs previously reported.
F3 Transaction pursuant to an existing 10b5-1 trading plan dated December 13, 2023 (fully executed as of December 14, 2023).